Why the study?
Does closed-loop-assisted goal-directed fluid therapy using a noninvasive cardiac output monitor improve hemodynamic parameters compared to a protocolized approach in patients undergoing moderate-risk laparoscopic abdominal surgery?
Does closed-loop-assisted goal-directed fluid therapy using a noninvasive cardiac output monitor improve hemodynamic parameters compared to a protocolized approach in patients undergoing moderate-risk laparoscopic abdominal surgery?
Personalized fluid therapy using noninvasive hemodynamic monitoring does not offer hemodynamic advantages over a protocolized approach in moderate-risk abdominal surgery.
No takes yet. Share an insight, caveat, or question.
Closed-loop fluid therapy offers no hemodynamic advantage over protocolized care in moderate-risk surgery; reinforces protocolized approaches as sufficient.
Joosten et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: